|
WO2020172177A1
|
|
Combinations of multiple chimeric antigen receptors for immunotherapy
|
|
WO2020163673A1
|
|
Inhibitors of adenylate-forming enzyme mene
|
|
EP3519581A1
|
|
Methods and kits for typing kir2dl alleles
|
|
WO2018005775A1
|
|
Cd47 blockade enhances therapeutic activity of antibodies to low density cancer epitopes
|
|
WO2017205746A1
|
|
Methods of differentiating stem cell-derived proprioceptors
|
|
WO2017106836A1
|
|
Triterpene saponin variants, methods of synthesis and use thereof
|
|
WO2017100432A1
|
|
Compositions and methods for the treatment of inflammatory bowel disease
|
|
WO2017062854A1
|
|
In vitro methods of identifying modulators of neuromuscular junction activity
|
|
WO2017023859A1
|
|
Antigen-binding proteins targeting cd56 and uses thereof
|
|
WO2017015152A1
|
|
Combination therapy using pdk1 and pi3k inhibitors
|
|
US2018015184A1
|
|
Method and composition to increase radiation-induced tumor therapeutic effects
|
|
WO2017008065A2
|
|
Vector constructs and methods for achieving or enhancing protein localization to the surface of cells
|
|
WO2016210129A1
|
|
Novel pd-1 immune modulating agents
|
|
WO2016191740A1
|
|
Methods for drug discovery
|
|
WO2016191567A1
|
|
System, method and computer-accessible medium for texture analysis of hepatopancreatobiliary diseases
|
|
WO2016191246A2
|
|
T cell receptor-like antibodies specific for a prame peptide
|
|
CA2985894A1
|
|
Use of phosphoinositide 3-kinase inhibitors for treatment of vascular malformations
|
|
WO2016176683A1
|
|
Catheter control mechanism with magnetic resonance imaging-compatible torque
|
|
WO2016161313A1
|
|
Apparatus and method for visualization and automatic localization of hollow organ for image guided precision medicine
|
|
WO2016154047A2
|
|
Monoclonal antigen-binding proteins to intracellular oncogene products
|
